Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Mitsu Chem Plast Ltd

MITSU
BSE
111.05
1.02%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Mitsu Chem Plast Ltd

MITSU
BSE
111.05
1.02%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
151Cr
Close
Close Price
111.05
Industry
Industry
Plastics - Others
PE
Price To Earnings
13.16
PS
Price To Sales
0.43
Revenue
Revenue
354Cr
Rev Gr TTM
Revenue Growth TTM
9.28%
PAT Gr TTM
PAT Growth TTM
74.92%
Peer Comparison
How does MITSU stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
MITSU
VS

Quarterly Results

Upcoming Results on
2 May 2026
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
838076738280818090859286
Growth YoY
Revenue Growth YoY%
11.5-5.78.92.5-1.10.57.29.510.06.413.86.9
Expenses
ExpensesCr
767570667575767582808776
Operating Profit
Operating ProfitCr
8558855685610
OPM
OPM%
9.16.37.210.59.16.05.86.89.15.96.411.2
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
222222222222
Depreciation
DepreciationCr
111222222222
PBT
PBTCr
422442225236
Tax
TaxCr
101110011012
PAT
PATCr
312331114125
Growth YoY
PAT Growth YoY%
0.0-73.8-2.675.7-14.2-19.3-24.0-53.525.120.264.9218.2
NPM
NPM%
4.01.72.04.33.41.41.41.83.91.52.05.5
EPS
EPS
2.61.11.22.62.30.80.81.12.61.01.43.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
8994112125139178258309311332354
Growth
Revenue Growth%
6.019.211.111.128.744.519.90.76.86.6
Expenses
ExpensesCr
8186103114123155232282286309325
Operating Profit
Operating ProfitCr
88101116232627262329
OPM
OPM%
9.28.98.68.411.412.910.08.68.37.08.1
Other Income
Other IncomeCr
01000110110
Interest Expense
Interest ExpenseCr
44446667976
Depreciation
DepreciationCr
22224455677
PBT
PBTCr
33446141615121015
Tax
TaxCr
11112453334
PAT
PATCr
223441012129711
Growth
PAT Growth%
27.742.53.410.7143.718.72.6-24.9-18.257.8
NPM
NPM%
2.12.63.12.92.95.44.53.82.92.23.2
EPS
EPS
4.92.23.11.03.27.89.39.57.15.48.4

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
144412121212131414
Reserves
ReservesCr
99182318283950678386
Current Liabilities
Current LiabilitiesCr
2828274044485870848081
Non Current Liabilities
Non Current LiabilitiesCr
1715203233373545311815
Total Liabilities
Total LiabilitiesCr
56566999108125144177194195196
Current Assets
Current AssetsCr
3331374045587989101100101
Non Current Assets
Non Current AssetsCr
2325325963676688939696
Total Assets
Total AssetsCr
56566999108125144177194195196

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
144618413722915
Investing Cash Flow
Investing Cash FlowCr
-4-4-7-30-8-7-3-27-12-8
Financing Cash Flow
Financing Cash FlowCr
-5-62113-5-233-7
Net Cash Flow
Net Cash FlowCr
5-51-1011-200
Free Cash Flow
Free Cash FlowCr
110-2-12-372-6-37
CFO To PAT
CFO To PAT%
716.8176.0167.1499.5110.6135.958.0186.3105.5209.1
CFO To EBITDA
CFO To EBITDA%
167.950.960.3170.027.757.026.082.736.465.1

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
062556983133303176188115
Price To Earnings
Price To Earnings
0.025.515.919.220.813.726.314.921.115.8
Price To Sales
Price To Sales
0.00.70.50.60.60.71.20.60.60.3
Price To Book
Price To Book
0.04.92.52.62.73.45.92.82.41.2
EV To EBITDA
EV To EBITDA
3.110.98.811.08.78.514.39.510.47.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
32.534.535.635.443.541.636.333.934.936.2
OPM
OPM%
9.28.98.68.411.412.910.08.68.37.0
NPM
NPM%
2.12.63.12.92.95.44.53.82.92.2
ROCE
ROCE%
15.315.815.011.013.919.118.615.513.010.2
ROE
ROE%
18.619.216.013.513.224.422.618.911.27.5
ROA
ROA%
3.44.35.03.63.77.88.06.74.63.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Mitsu Chem Plast Limited (BSE: 540078) is a leading Indian manufacturer of polymer-based blow-molded and injection-molded plastic products, specializing in technically advanced, customized, and sustainable solutions. With over **35 years of industry experience**, the company has evolved from a single-unit operation in 1990 into a multi-facility, export-oriented enterprise serving global OEM clients across pharmaceuticals, healthcare, FMCG, chemicals, automotive, and infrastructure sectors. --- ### **Business Segments & Product Portfolio** Mitsu Chem Plast operates across four core verticals: 1. **Molded Industrial Packaging** (dominant segment – ~86% of revenue) - Products: Drums, jerry cans, bottles, jars (100 mL to 250 L), pails, totes, pallets, caps, closures (GL 45, TSV 40), and accessories. - Serves: Chemicals, pharmaceuticals, food & beverage, agrochemicals, lube oil, FMCG, and specialty chemicals industries. - Recent launches: - **Pail Container** – Leak-proof, stackable design for liquids, powders, and solids. - **MiEcoPET** (May 2024) – Sustainable packaging with 30–60% recycled PET; reduces raw material use by 30–50% vs. HDPE. 2. **Hospital & Healthcare Furniture Components** (11–12% of revenue; fast-growing) - Products: Bed panels, bedside lockers, siderails, IV stands, CPR/spine boards, over-bed tables, and trolleys. - Served via **Furnastra**, a dedicated brand launched in FY24–25 to strengthen market identity in healthcare. - Key innovation: **Patented CPR-enabled profile** built into the back of hospital bed components for emergency resuscitation. 3. **Medical Devices** - Products: Pregnancy kits, malaria/HIV diagnostic kits, inhalers – compliant with regulated healthcare markets. 4. **Infrastructure & Automotive Components** - **Infrastructure**: Chair shells for schools, buses, stadiums, and public institutions. - **Automotive**: Washer tanks, rainhoods, air ducts, filters. --- ### **Strategic Initiatives & Growth Drivers** #### **1. Furnastra – Dedicated Healthcare Brand** - Launched in May 2025 and publicly unveiled at **Arab Health, Dubai (Jan 2025)**. - Focus: Durable, ergonomic, customizable, and patient-centric hospital furniture solutions. - Achieved **over 60% domestic market share in ABS panels for hospital furniture**. - Targeting both domestic and international expansion in healthcare, especially via export participation in **MEDICA, Arab Health, and WXH**. #### **2. Export Growth & Global Expansion** - **Exports to 17+ countries** (USA, UK, Germany, UAE, Saudi Arabia, Japan, Spain, Poland, Malaysia, Maldives, etc.). - **144% YoY export growth in FY25** – primarily driven by hospital furniture parts and industrial packaging. - Expanding presence in: - **Middle East & North Africa**: UAE, Saudi Arabia, Egypt, Kuwait. - **Europe**: UK, Germany, France, Spain, Poland. - **Asia & Americas**: USA, Israel, Turkey, Maldives. - Participating in major global trade fairs to enhance visibility and secure OEM client partnerships. #### **3. Capacity Expansion & Manufacturing Excellence** - **Three manufacturing units** in Maharashtra: - **Tarapur (Boisar)**: Two units (20,000 sq. ft. and 36,000 sq. ft.). - **Khalapur**: 96,000 sq. ft. state-of-the-art facility established in 2018–19. - **Total manufacturing footprint**: Over **152,000 sq. ft.**. - **Installed capacity**: - **28,424 MT/year → 29,079 MT/year (Nov 2025)** – a 655 MT increase. - Fully funded via internal accruals (₹85 lakh investment). - Enhanced by **51 blow molding machines** and **18 injection molding machines (60–450 tonnes clamping force)**. - Supports faster scaling of new products and reduced turnaround times. #### **4. R&D & Innovation** - Strong in-house **R&D team** focused on: - Sustainable product development (e.g., MiEcoPET). - Import substitution in line with **‘Make in India’**. - Designing customized solutions for regulated markets (pharma, healthcare). - Pipeline includes stackable PET containers for lubricants, paints, and FMCG sectors. #### **5. Distribution & Supply Chain** - **Dedicated depots** in Hyderabad (South India) and Delhi (North India) for efficient logistics. - Nationwide distribution from Jammu to Chennai. - Distributor network supports pan-India service. --- ### **Financial Highlights (FY25)** - **Revenue**: ₹332.28 crore (up from ₹100 crore in FY15). - **Revenue Mix**: - Molded Industrial Packaging: **86.19%** (₹286.39 crore) - Hospital Furniture Parts: **11.55%** (₹38.38 crore) - Infrastructure & Others: **2.26%** (₹7.51 crore) - **Export Revenue**: ₹140.08 lakhs in FY24–25 (rapidly growing). --- ### **Corporate Profile** - **Founded**: 1990 (Tarapur, Maharashtra) - **Headquarters**: Maharashtra, India - **Listed**: BSE SME (2016) → Migrated to **BSE Main Board (2020)** - **Certifications**: Certified polymer manufacturer with **in-house testing and QC systems**. - **Client Base**: **Over 500 customers**, including **30+ Fortune 500 companies** in India. - **Workforce & Expertise**: Supported by experienced professionals in manufacturing, R&D, and quality assurance. --- ### **Key Challenges & Responses** - **Raw Material Volatility**: HDPE, PP, and filled PP costs linked to crude oil. - Strategy: Monthly pricing adjustments; 80–90% pass-through to customers. - **Export Logistics**: Bulkiness of products makes shipping costly. - Strategy: Focus on high-value, lower-bulk components (e.g., medical kits, furniture parts). - **New Market Entry**: Pail container segment has high barriers. - Status: Secured small orders; pursuing large OEM onboarding. ---